期刊文献+

哺乳动物雷帕霉素靶蛋白介导细胞自噬在肿瘤中的研究进展 被引量:4

Research progress of cell autophagy mediated by mammalian target of rapamycin associated with tumor
下载PDF
导出
摘要 自噬与肿瘤细胞的恶性转化和分化有关。哺乳动物雷帕霉素靶蛋白(mTOR)通路和细胞自噬关系密切,其可通过调控细胞自噬而在肿瘤的发生和发展中发挥重要的作用。目前mTOR抑制剂(靶向抑制信号通路)的开发已成为抗肿瘤研究的重要领域,这将会是潜在的肿瘤治疗方法。本文就自噬通路中mTOR信号通路与肿瘤关系以及mTOR抑制剂的研究进展进行综述,希望能为肿瘤的研究及靶向药物的研制提供信息。 Autophagy capacity may correlate with malignant transformation and differentiation of cancer cells. The mammalian target of rapamycin(mTOR) has close relationship with autophagy, which can play an important role through regulating the autophagic activity on cancer genesis and progression. So far mTOR inhibitors(inhibiting targets of signaling pathways) have potential in the future for cancer therapy, the development of mTOR inhibitors represents an important field in anticancer research. This article summarizes the relationship between mTOR signaling pathway and tumor in autophagy pathways, and the current status of the development of mTOR inhibitors, it hopes to provide information for studies on cancer research and targets for tumor therapy.
作者 张浩然 乔旭旭 毕明宏 ZHANG Haoran;QIAO Xuxu;BI Minghong(Department of Medical Oneology,the First Affiliated Hospital of Bengbu Medical College,Anhui Province,Bengbu 233004,China)
出处 《中国医药导报》 CAS 2018年第25期32-35,共4页 China Medical Herald
基金 安徽省高校自然科学研究项目(重点项目)(KJ2016A483) 蚌埠医学院科技发展基金项目(BYKF1403)
关键词 自噬 肿瘤 哺乳动物雷帕霉素靶蛋白 治疗 研究进展 Autophagy Tumor Mammalian target of rapamyein Therapy Research progress
  • 相关文献

参考文献3

二级参考文献95

  • 1程元荣,黄捷.抗真菌抗生素和免疫抑制剂[J].中国新药杂志,2005,14(3):268-273. 被引量:4
  • 2DEMIDENKO ZN, SHTUTMAN M, BLAGOSKLONNY MV. Pharmacologic inhibition of MEK and PI-3K converges on the mTORI S6 pathway to decelerate cellular senescence [J]. Cell Cycle, 2009, 8 (12) : 1896 -1900.
  • 3SARBASSOV DD, GUERTIN DA, ALI SM, et al. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex [J]. Science, 2005. 307 (5712) : 1098 - 1101.
  • 4GARCIA-MARTfNEZ JM, ALESSI DR. mTOR complex 2 ( mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1) [J]. Chem J,2008,416(3) :375 -385.
  • 5JACINTO E. LOEWITH R. SCHMIDT A. et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive [J]. Nat Cell Biol, 2004, 6(11): 1122-1128.
  • 6SARBASSOV DD, ALI SM, KIM DH, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton [J]. Curr Biol , 2004,14(14) :1296-1302.
  • 7ROSNER M, FUCHS C, SIEGEL N, et al. Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle[J]. Hum Mol Genet, 2009, 18(17) :3298 -3310.
  • 8FOSTER KG, FINGAR DC. Mammalian target of rapamycin (mTOR) : conducting the cellular signaling symphony [J]. J Biol Chem, 2010, 285 (19) : 14071 - 14077.
  • 9XU L, SALLOUM D, MEDLIN PS, et al. Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORCI) [J]. J Biol Chem, 2011, 286 (29) : 25477 - 25486.
  • 10YOSHIDA S, HONG S, SUZUKI T, et al. Redox regulstes mammalian target of rapamycin complex I ( mTORCI) activity by modulating the TSC1/TSC2-Rheb GTPase pathway [J]. J Bioll Chem, 2011 , 286 (37) :32651 - 32660.

共引文献14

同被引文献29

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部